Clinical Trial

Feasibility of Group-Based Metacognitive Therapy for PTSD

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to investigate the feasibility and acceptability of group-based Metacognitive Therapy (MCT) for post-traumatic stress disorder (PTSD) when delivered within routine psychiatric care in Sweden. The secondary objective is to evaluate preliminary treatment effects of group-based MCT on symptoms of post-traumatic stress, complex PTSD, depression, and quality of life, and to compare treatment dropout rates to those reported in the existing literature on exposure-based treatments for PTSD.
Trial Details
NCT Number NCT07302334
Lead Sponsor Karolinska Institutet
Collaborators: Region Stockholm
Conditions PTSD
Enrollment 30 participants
Start Date 2025-11-28
Primary Completion 2026-08-28 (estimated)
Study Completion 2026-11-28 (estimated)
Updated on ClinicalTrials.gov 2025-12-24